Rankings
▼
Calendar
RVMD FY 2017 Earnings — Revolution Medicines, Inc. Revenue & Financial Results | Market Cap Arena
RVMD
Revolution Medicines, Inc.
$19B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$27M
Operating Income
-$31M
Net Income
-$31M
EPS (Diluted)
$-0.85
Cash Flow
Operating Cash Flow
-$25M
Free Cash Flow
-$27M
Stock-Based Comp.
$141,000
Balance Sheet
Total Assets
$15M
Total Liabilities
$11M
Stockholders' Equity
$5M
Cash & Equivalents
$9M
← FY 2018
All Quarters